Atıf Formatları
The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

İ. E. GÜRER Et Al. , "The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2, pp.197-199, 2000

GÜRER, İ. E. Et Al. 2000. The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2 , 197-199.

GÜRER, İ. E., Simsek, T., Erdogan, G., Atalay, E., Zorlu, C., Karaveli, S., ... Erman, O.(2000). The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2, 197-199.

GÜRER, İNANÇ Et Al. "The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2, 197-199, 2000

GÜRER, İNANÇ E. Et Al. "The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2, pp.197-199, 2000

GÜRER, İ. E. Et Al. (2000) . "The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.21, no.2, pp.197-199.

@article{article, author={İNANÇ ELİF GÜRER Et Al. }, title={The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?}, journal={EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY}, year=2000, pages={197-199} }